One major feature of the existing drug-development industry is that diseases with little profit-
making potential fail to attract badly needed investment. But a new organization may change …

Of 1393 new pharmaceuticals marketed between 1975 and 1999, only 16 were for tropical
diseases and tuberculosis. This finding from an exhaustive review of international, European …

Philanthropists, drugmakers and governments all agree: the world's poor are in dire need of
new drugs for neglected diseases, but there is not enough money available to develop …

The Paris-based charity Mé decins Sans FrontiÃres (MSF) has launched plans for an
ambitious international effort to research, develop and produce drugs for neglected diseases …

There is a lack of effective, safe, and affordable pharmaceuticals to control infectious
diseases that cause high mortality and morbidity among poor people in the developing …

Why do life-saving prescription drugs cost so much? Drug companies insist that prices
reflect the millions they invest in research and development. In this gripping exposé, Merrill …

New Drugs for Neglected Diseases: From Pipeline to Patients | PLOS Medicine Skip to main
content Advertisement PLOS Medicine Browse Current Issue Journal Archive Special Issues …

Drug Companies Are Focusing on the Poor After Decades of Ignoring Them Page 1 Drug
Companies Are Focusing on the Poor After Decades of Ignoring Them The pharmaceutical …

Drug discovery for neglected diseases | Nature Reviews Drug Discovery Skip to main content
Thank you for visiting nature.com. You are using a browser version with limited support for …

There is a “chronic lack of effec-tive, affordable, easy-to-use medications for neglected
diseases”, asserted Els Torreele (Free University of Brussels, Belgium) last week. Torreele's …